International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

Despite increasing availability of therapies, patients with Sezary syndrome (SS) commonly endure multi-line treatment journeys, mostly with partial responses of short duration. Measuring clinical benefit is challenging; time-to-next-treatment (TTNT) provides a robust, objective measurement of effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Belinda A., Dobos, Gabor, Haider, Zahra, Prince, H. Miles, Bagot, Martine, Evison, Felicity, van der Weyden, Carrie, McCormack, Chris, Ram-Wolff, Caroline, Miladi, Maryam, Scarisbrick, Julia J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628811/
https://www.ncbi.nlm.nih.gov/pubmed/37648672
http://dx.doi.org/10.1182/bloodadvances.2023011041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628811/
https://www.ncbi.nlm.nih.gov/pubmed/37648672
http://dx.doi.org/10.1182/bloodadvances.2023011041

Ejemplares similares